Agnikul manufactures the Agnibaan, a customizable two-stage launch vehicle capable of delivering payloads up to 100 kg to various orbits using LOX/Kerosene engines. The startup simplifies the earth-to-space journey by providing quick, affordable, and flexible launch solutions from over ten launch ports.

Alyssum Therapeutics is developing AT1965, a small molecule that inhibits CMTR2 in cancer cells to enhance B cell immune responses against solid tumors. This approach targets the recruitment and activation of B cells, which are crucial for improving survival outcomes in patients with advanced malignancies and autoimmune diseases.

Ather Energy manufactures electric scooters equipped with smart technology, including Ather Connect for navigation and real-time alerts, and offers a robust fast-charging network with over 3,100 charging stations across India. The company addresses the need for sustainable urban transportation by providing efficient electric mobility solutions that reduce reliance on fossil fuels.

Fasal is an AI-driven IoT platform that provides real-time, farm-specific data on microclimatic conditions, irrigation needs, and pest risks to optimize crop management. By delivering precise recommendations, Fasal helps farmers reduce water usage by up to 82.8 billion liters and decrease pesticide costs by up to 60%, ultimately increasing crop yields by up to 40%.

The startup offers an AI-powered visual inspection platform that automates quality control processes in manufacturing. By utilizing machine learning algorithms, the platform enables manufacturers to significantly lower inspection costs and enhance defect detection rates.

GalaxEye is developing the world's first hybrid imaging satellites that combine Synthetic Aperture Radar (SAR) and Multispectral Imaging (MSI) to provide high-resolution, all-weather data for various industries. This technology enables precise monitoring of military activities, agricultural growth, and urban changes, facilitating informed decision-making for businesses and governments.

This medical technology firm develops portable, non-invasive photon-based devices for various applications. Their offerings include laser spectroscopy, microscopes, and AI-powered technology, enabling non-destructive process and quality control solutions.

Morphing Machines Pvt Ltd develops the REDEFINE™ technology, a runtime reconfigurable many-core processor architecture that optimizes performance and power efficiency for compute-intensive applications. This technology addresses the limitations of traditional ASIC designs by providing high performance at a lower non-recurring engineering cost, enabling faster deployment across various sectors such as avionics, automotive, and telecommunications.

Orangewood Labs develops AI-powered robotic arms designed for collaborative use in manufacturing environments, enabling tasks such as bin picking, visual inspection, and powder coating. These robotic systems reduce manual labor, enhance precision, and improve operational efficiency, allowing workers to focus on higher-value activities.

This startup develops 3D printing technology specifically for the construction industry, enabling the digitization of building processes through advanced manufacturing and automation systems. By facilitating deep personalization, the company enhances productivity and provides customers with a seamless end-to-end construction experience.

The startup offers a logistics automation platform that utilizes swarm intelligence and artificial intelligence algorithms to enhance parcel sorting efficiency with a robotic system. This technology enables logistics companies to significantly increase sorting and order consolidation productivity while minimizing the required warehousing space.

We design, manufacture, and deploy full‑stack UAV systems for defense, including battle‑ready drones for reconnaissance and intelligence. Our portfolio features precision‑engineered flight controllers, ESCs, RTK‑GPS, and a disposable nano drone, with demonstrated swarm capability of ten coordinated drones operating for 45 minutes.

Vyome operates a three‑pillar healthcare platform that combines biotech drug development, medical‑device acquisition, and AI‑driven data analytics to create therapies for underserved immuno‑inflammatory conditions. It advances clinical‑stage treatments such as VT1953 for malignant fungating wounds, an IMPDH‑targeting candidate for steroid‑intolerant uveitis, and VB1953 for antibiotic‑resistant acne, while leveraging cross‑border US‑India R&D and AI insights to accelerate development and improve patient outcomes.

The startup develops an energy conservation platform that integrates advanced power electronics with building management systems to optimize air conditioning efficiency. This technology reduces electricity consumption, enabling clients to lower their energy costs significantly.